Short communication · 31 Mar 2025
Research articlePublished 23 Feb 2023
Recent Research on Tumor Markers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and Objectives: Tumor markers are burgeoning concept in the healthcare industry. It has not been fool proof in that their levels may fluctuate with time, may not rise consistently in all cancers, may be present in considerable amount in non-cancer patients, standardization has not been done. But their ease of assay with ELISA and chemiluminescence immunoassay techniques with just a blood sample collected in the clot activator vacationer, allowed to clot and the tube centrifuged to separate the serum and cells, and the serum is analysed using Beckman coulter Access 2 auto analyzer. It is convenient, time saving, cost effective, and large number of patient samples can be processed in a short time. It gives valuable information about the screening, diagnoses, prognosis, monitoring, surveillance, and progression of cancer in all stages, about planning treatment and monitoring recurrence. Lately a surrogate marker for tissue biopsy, called the liquid biopsy has come in vogue where the plasma is analysed for circulating tumor cells or circulating tumor DNA. The implications of tumor marker research will gain momentum with advancement of molecular diagnoses. Keywords Tumor Index Substances; Immunoassay; Liquid Biopsy; Single Nucleotide Polymorphism
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 26 Aug 2022
Recent Advances in the Treatment of Metastatic Brain Tumor
Brief report · 28 Feb 2022
A Report on Pediatric Brain Tumor Recent Findings
Review article · 2016
Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy
Short communication · 2016
Tumor Suppressor Gene ARID1A in Cancer: Recent Advances and Future Perspective
More from this journal
The newest in Translational Biomedicine.
Research article · 30 Dec 2024
An Examination of the Correlation between Advancements in TBI Research and the Long-Term Health Outcomes of High-Risk Populations: The Use of Biomarkers vs. Symptom Assessment
Perspective · 20 Dec 2024
Preclinical and Animal Studies in Translational Biomedicine: Bridging the Gap Between Bench and Bedside
Perspective · 20 Dec 2024
Regenerative Medicine in Translational Biomedicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Biomedicine
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Nabaneeta Mahata”

